Literature DB >> 29410905

Author's Reply.

Paweł Miotła1.   

Abstract

Entities:  

Year:  2017        PMID: 29410905      PMCID: PMC5791417          DOI: 10.5173/ceju.2017.1602

Source DB:  PubMed          Journal:  Cent European J Urol        ISSN: 2080-4806


× No keyword cloud information.
We are grateful for the comments by Peter Petros on our recent publication addressing the diagnostic and therapeutic recommendations for patients with nocturia. We agree that there is a bulk of evidence that pelvic reconstructive surgery can improve urgency and nocturia. Unfortunately, we did not find any published evidence to support the statement that surgical techniques are able to improve nocturnal polyuria. The treatment of nocturia depends on causes of this disorder and we have mentioned in our paper that the aim of this article was to present diagnostic and therapeutic guidelines in the case of nocturnal polyuria [1]. As we have concluded, desmopressin is an effective and safe first-line treatment option in the pharmacological therapy of nocturia caused by nocturnal polyuria – which is present up to 83% of patients with nocturia [2]. Van Kerrebroeck et al. described a significant decrease in the number of nocturnal voids (33%) in patients with nocturia treated with desmporessin [3]. Thus, to reiterate, unfortunately, we did not find any published evidence to support the statement that surgical techniques are able to improve nocturnal polyuria. We have also concluded that the addition of desmopressin should be considered in the treatment of an overactive bladder with underlying nocturnal polyuria. Rovner et al. have demonstrated the significant benefits of low-dose desmopressin combined with tolterodine for treating nocturia in women with overactive bladder [4]. Such strategy has been also mentioned in other recently published recommendations for practical management of nocturia [5]. The author of the letter had concluded that ‘urge incontinence is the key symptom for overactive bladder’. According to the International Continence Society, overactive bladder is a symptom-defined condition characterised by urinary urgency, with or without urgency urinary incontinence, usually with increased daytime frequency and nocturia [6]. In the EpiLUTS study, the most common reported storage symptom was urgency, not urgency urinary incontinence. This condition was observed in 35.7% of all women in the study, clinically significant nocturia (≥2 episodes) (33.7%) followed, while urgency urinary incontinence (24.4%) was subsequent [7].
  6 in total

1.  Is nocturia equally common among men and women? A population based study in Finland.

Authors:  Kari A O Tikkinen; Teuvo L J Tammela; Heini Huhtala; Anssi Auvinen
Journal:  J Urol       Date:  2006-02       Impact factor: 7.450

2.  Low-dose Desmopressin and Tolterodine Combination Therapy for Treating Nocturia in Women with Overactive Bladder: A Double-blind, Randomized, Controlled Study.

Authors:  Eric S Rovner; Kyle Raymond; Eugene Andruczyk; Kristian V Juul
Journal:  Low Urin Tract Symptoms       Date:  2017-05-31       Impact factor: 1.592

3.  The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study.

Authors:  Karin S Coyne; Chris C Sexton; Christine L Thompson; Ian Milsom; Debra Irwin; Zoe S Kopp; Christopher R Chapple; Steven Kaplan; Andrea Tubaro; Lalitha P Aiyer; Alan J Wein
Journal:  BJU Int       Date:  2009-03-05       Impact factor: 5.588

Review 4.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.

Authors:  Bernard T Haylen; Dirk de Ridder; Robert M Freeman; Steven E Swift; Bary Berghmans; Joseph Lee; Ash Monga; Eckhard Petri; Diaa E Rizk; Peter K Sand; Gabriel N Schaer
Journal:  Neurourol Urodyn       Date:  2010       Impact factor: 2.696

5.  Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study.

Authors:  Philip van Kerrebroeck; Masoumeh Rezapour; Ariane Cortesse; Joachim Thüroff; Anders Riis; Jens Peter Nørgaard
Journal:  Eur Urol       Date:  2007-01-16       Impact factor: 20.096

Review 6.  A practical approach to the management of nocturia.

Authors:  Matthias Oelke; Stefan De Wachter; Marcus J Drake; Antonella Giannantoni; Mike Kirby; Susan Orme; Jonathan Rees; Philip van Kerrebroeck; Karel Everaert
Journal:  Int J Clin Pract       Date:  2017-10-05       Impact factor: 2.503

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.